<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Smile05person</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Smile05person"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Smile05person"/>
		<updated>2026-04-21T06:21:37Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Qiagen_Tgf_Beta&amp;diff=195725</id>
		<title>Qiagen Tgf Beta</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Qiagen_Tgf_Beta&amp;diff=195725"/>
				<updated>2017-06-29T08:37:54Z</updated>
		
		<summary type="html">&lt;p&gt;Smile05person: Створена сторінка: ts had been recruited for this study. Entire blood samples have been collected from 360 individuals with CVD from St.Thomas Hospital, Kerala, India. [http://www...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ts had been recruited for this study. Entire blood samples have been collected from 360 individuals with CVD from St.Thomas Hospital, Kerala, India. [http://www.ncbi.nlm.nih.gov/pubmed/1516647 1516647] Diagnosis of CVD was primarily based on physical examination and Doppler ultrasound test. CVD resulting from obstructions for example neoplasm have been excluded in the study. Differential diagnosis was performed by an skilled vascular surgeon and presence of distichiasis was ruled out by an ophthalmologist. Sufferers with type two diabetes mellitus have been also excluded since genetic variants of FoxC2 happen to be reported to outcome in susceptibility to diabetes mellitus. Blood samples were collected from age and gender matched 352 healthier controls with no known loved ones history for CVD. For tissue level expression analysis, varicose vein tissue samples were collected from 22 patients admitted for remedy of CVD by operative treatments at Kempegowda Institute of Medical Sciences, Bangalore, India. [http://www.medchemexpress.com/JTC-801.html JTC-801 site] Saphenous manage vein samples from 20 patients who underwent coronary artery bypass graft surgery at Sri Jayadeva Institute for Cardiovascular Sciences &amp;amp; Research, Bangalore, India have been also collected for the study. Complete blood samples have been also collected from these 22 sufferers and 20 controls for sequencing assays. Relevant data regarding the clinical characteristics of sufferers had been collected from healthcare records of the hospitals participating inside the study. Variables Family members history Bleeding Thrombophlebitis Cellulitis LL oedema Pigmentation Ulceration CEAP Class two 3 4 5 6 N = 382 n 257 29 3 5 89 185 56 48 11 223 73 27 Data evaluation Demographic data of all study participants and information regarding symptoms which include pain, itching and throbbing sensation in legs and clinical signs which include hemorrhage, lower limb oedema, Percentages have been taken in the column totals. doi:10.1371/journal.pone.0090682.t002 FoxC2 in Chronic Venous Disease a b Genotypes c.-350G.T GG GT TT GT/TT c.-512C.T c CC CT TT CT/TT c.-1538A.G c AA AG GG AG/GG c Patients n Controls n OR P-value AOR 342 37 3 40 325 46 1 47 1 0.76 two.85 0.81 0.353 0.72 69 209 104 313 118 170 84 254 1 2.1 2.12 two.11 ,0.001 two.37 2.44 two.08 240 100 42 142 280 90 two 92 1 1.3 24.5 1.8 ,0.001 1.22 25.58 1.8 Percentages were taken from the column totals. Chi-square test for measure of association was used to derive p value. aOdds ratio and 95% confidence intervals of individual polymorphisms. b Adjusted odds ratio and 95% confidence intervals is obtained adjusting for age group and sex in multiple logistic regression model. c Polymorphism previously reported inside the Entrez single nucleotide polymorphism database. doi:10.1371/journal.pone.0090682.t003 hyperpigmentation, thrombophlebitis, cellulitis and ulceration have been collected for each patient from healthcare records. Family members history, occupational and lifestyle data were collected to examine their influence in aggravating disease manifestation. Disease phenotypes were categorized according to CEAP classification system. Varicose veins without odema or pigmentation had been classified under C2. Only two.9% of all our patients have been in CEAP Class 3 in which varicose vein with oedema alone are found.&lt;/div&gt;</summary>
		<author><name>Smile05person</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Tgf_Beta_Cell_Proliferation&amp;diff=194770</id>
		<title>Tgf Beta Cell Proliferation</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Tgf_Beta_Cell_Proliferation&amp;diff=194770"/>
				<updated>2017-06-27T06:34:56Z</updated>
		
		<summary type="html">&lt;p&gt;Smile05person: Створена сторінка: 8 0.71 0.77 0.086 0.86 129 228 25 253 294 77 1 78 1 6.75 56.98 7.39 ,0.001 6.35 57.01 six.69 348 34 352 20 1 1.72 0.061 two.39 221 161 161 308 64 64 1 3.51 thre...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;8 0.71 0.77 0.086 0.86 129 228 25 253 294 77 1 78 1 6.75 56.98 7.39 ,0.001 6.35 57.01 six.69 348 34 352 20 1 1.72 0.061 two.39 221 161 161 308 64 64 1 3.51 three.51 ,0.001 a four.31 4.31 Percentages have been taken from the column totals. Chi-square test for measure of association was applied to derive p value. Odds ratio and 95% self-confidence intervals of individual polymorphisms. bAdjusted odds ratio and 95% confidence intervals is obtained adjusting for age group and sex in various logistic regression model. doi:10.1371/journal.pone.0090682.t004 3 FoxC2 in Chronic Venous Illness PCR DNA sequencing A touch-down PCR was performed to amplify the single coding exon, 3 kb of 59 flanking and 200 bp of 39flanking area which involves the 59 and 39 untranslated  regions of FoxC2 gene from DNA of individuals with CVD and healthier subjects. Nine primer pairs to amplify overlapping regions of FoxC2 gene and flanking regions were designed employing Primer Premier five [http://www.medchemexpress.com/PAK4-IN-1.html order PAK4-IN-1] application. PCR conditions have been as follows: Initial denaturation for 5 min at 96uC, 20 cycles of denaturing at 96uC for 30 sec, annealing at 70uC for 40 sec using a touchdown of 0.5uC per cycle and extension at 72uC for 1.5 min. This was followed by 20 cycles at identical situations except that annealing was at 60uC for 40 sec. PCR products have been purified making use of gel band elution kit. DNA sequencing was carried out on an ABI 3100 DNA analyzer with Bigdye terminator chemistry. Variables c.-512C.T C T c.-1538A.G A G c.-2647A.T A T c.126G.A G A Controls n Instances n P value 288 254 278 313 0.04 370 92 340 142 0.001 371 78 357 253,0.001 372 64 382 161,0.001 Gene expression analysis of FoxC2 by qRT-PCR Total RNA from every tissue sample was subjected to reverse transcription with oligodT, dNTPs, and M-MLV reverse transcriptase. Primers for FoxC2 and GAPDH genes were designed for real time PCR evaluation. Quantitative RT-PCR was carried out as reported earlier. The temperature conditions have been as follows: 48uC, 30 min; 95uC, 10 min; followed by 40 cycles of 95uC,15 s; and 60uC, 1 min and analyzed making use of ABI Prism 7900HT sequence detection method. Values were normalized with GAPDH mRNA levels. A single peak was observed inside the dissociation curve  for both genes confirming the specificity of PCR solutions. Actual time mRNA fold modify was calculated by the formula, 22DDCt. Percentages were taken in the column totals. Chi-squared test for measure of association was employed to derive p value. doi:ten.1371/journal.pone.0090682.t005 Genomic DNA and mRNA extraction Genomic DNA from complete blood samples was extracted making use of QIAamp DNA blood mini kit in accordance with the manufacturer's instructions. Genomic DNA and mRNA from vein tissues have been extracted by All Prep DNA/RNA/Protein mini kit. Quantification and purity of DNA and mRNA was measured by nanodrop-1000 spectrophotometer at 260 nm.&lt;/div&gt;</summary>
		<author><name>Smile05person</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Quilling_Jak_Zrobi%5CU0107&amp;diff=194409</id>
		<title>Quilling Jak Zrobi\U0107</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Quilling_Jak_Zrobi%5CU0107&amp;diff=194409"/>
				<updated>2017-06-26T07:24:50Z</updated>
		
		<summary type="html">&lt;p&gt;Smile05person: Створена сторінка: ts have been recruited for this study. Whole blood samples were collected from 360 sufferers with CVD from St.Thomas Hospital, Kerala, India. Diagnosis of CVD w...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ts have been recruited for this study. Whole blood samples were collected from 360 sufferers with CVD from St.Thomas Hospital, Kerala, India. Diagnosis of CVD was primarily based on physical examination and Doppler ultrasound test. CVD resulting from obstructions including neoplasm have been excluded in the study. Differential diagnosis was performed by an experienced vascular surgeon and presence of distichiasis was ruled out by an ophthalmologist. Sufferers with sort two diabetes mellitus have been also excluded considering that genetic variants of FoxC2 have already been reported to result in susceptibility to diabetes mellitus. Blood samples were collected from age and gender matched 352 wholesome controls with no known family members history for CVD. For tissue level expression analysis, varicose vein tissue samples had been collected from 22 individuals admitted for remedy of CVD by operative treatment options at [http://www.medchemexpress.com/PAK4-IN-1.html KPT-9274 site] Kempegowda Institute of Medical Sciences, Bangalore, India. Saphenous control vein samples  from 20 patients who underwent coronary artery bypass graft surgery at Sri Jayadeva Institute for Cardiovascular Sciences &amp;amp; Research, Bangalore, India have been also collected for the study. Entire blood samples had been also collected from these 22 sufferers and 20 controls for sequencing assays. Relevant data regarding the clinical characteristics of individuals had been collected from health-related records of the  hospitals participating in the study. Variables Household history Bleeding Thrombophlebitis Cellulitis LL oedema Pigmentation Ulceration CEAP Class 2 3 4 5 6 N = 382 n 257 29 3 5 89 185 56 48 11 223 73 27 Data evaluation Demographic data of all study participants and information regarding symptoms like pain, itching and throbbing sensation in legs and clinical signs like hemorrhage, lower limb oedema, Percentages have been taken in the column totals. doi:10.1371/journal.pone.0090682.t002 FoxC2 in Chronic Venous Disease a b Genotypes c.-350G.T GG GT TT GT/TT c.-512C.T c CC CT TT CT/TT c.-1538A.G c AA AG GG AG/GG c Patients n Controls n OR P-value AOR 342 37 3 40 325 46 1 47 1 0.76 two.85 0.81 0.353 0.72 69 209 104 313 118 170 84 254 1 2.1 two.12 2.11 ,0.001 2.37 two.44 2.08 240 100 42 142 280 90 two 92 1 1.3 24.5 1.8 ,0.001 1.22 25.58 1.8 Percentages had been taken in the column totals. Chi-square test for measure of association was used to derive p value. aOdds ratio and 95% confidence intervals of individual polymorphisms. b Adjusted odds ratio and 95% confidence intervals is obtained adjusting for age group and sex in multiple logistic regression model. c Polymorphism previously reported in the Entrez single nucleotide polymorphism database. doi:10.1371/journal.pone.0090682.t003 hyperpigmentation, thrombophlebitis, cellulitis and ulceration had been collected for each patient from medical records. Loved ones history, occupational and lifestyle data have been collected to examine their influence in aggravating disease manifestation. Disease phenotypes were categorized according to CEAP classification system. Varicose veins without odema or pigmentation have been classified under C2. Only 2.9% of all our individuals have been in CEAP Class 3 in which varicose vein with oedema alone are found.&lt;/div&gt;</summary>
		<author><name>Smile05person</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Anti_Tgf_Beta_1_Antibody&amp;diff=189404</id>
		<title>Anti Tgf Beta 1 Antibody</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Anti_Tgf_Beta_1_Antibody&amp;diff=189404"/>
				<updated>2017-06-15T05:58:59Z</updated>
		
		<summary type="html">&lt;p&gt;Smile05person: Створена сторінка: 8 0.71 0.77 0.086 0.86 129 228 25 253 294 77 1 78 1 6.75 56.98 7.39 ,0.001 six.35 57.01 six.69 348 34 352 20 1 1.72 0.061 two.39 221 161 161 308 64 64 1 three.5...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;8 0.71 0.77 0.086 0.86 129 228 25 253 294 77 1 78 1 6.75 56.98 7.39 ,0.001 six.35 57.01 six.69 348 34 352 20 1 1.72 0.061 two.39 221 161 161 308 64 64 1 three.51 3.51 ,0.001 a 4.31 4.31 Percentages have been taken in the column totals. Chi-square test for measure of association was applied to derive p value. Odds ratio and 95% self-confidence intervals of person polymorphisms. bAdjusted odds ratio and 95% self-assurance intervals is obtained adjusting for age group and sex in various logistic regression model. doi:ten.1371/journal.pone.0090682.t004 three FoxC2 in Chronic Venous Disease PCR DNA sequencing A touch-down PCR was performed to amplify the single coding exon, 3 kb of 59 flanking and 200 bp of 39flanking area which includes the 59 and 39 untranslated  regions of FoxC2 gene from DNA of patients with CVD and healthier subjects. Nine primer pairs to amplify overlapping regions of FoxC2 gene and flanking regions were made utilizing Primer Premier five software. PCR circumstances have been as follows: Initial denaturation for five min at 96uC, 20 cycles of denaturing at 96uC for 30 sec, annealing at 70uC for 40 sec with a touchdown of 0.5uC per cycle and extension at 72uC for 1.five min. This was followed by 20 cycles at same situations except that annealing was at 60uC for 40 sec. PCR products were purified using gel band elution kit. DNA sequencing was carried out on an ABI 3100 DNA analyzer with Bigdye terminator chemistry. Variables c.-512C.T C T c.-1538A.G A G c.-2647A.T A T c.126G.A G A Controls n Instances n P worth 288 254 278 313 0.04 370 92 340 142 0.001 371 78 357 253,0.001 372 64 382 161,0.001 Gene expression evaluation of FoxC2 by qRT-PCR Total RNA from each tissue sample was [http://www.medchemexpress.com/tebipenem-pivoxil.html L-084 supplier] subjected to reverse transcription with oligodT, dNTPs, and M-MLV reverse transcriptase. Primers for FoxC2 and GAPDH genes were developed for actual time PCR evaluation. Quantitative RT-PCR was carried out as reported earlier. The temperature conditions were as follows: 48uC, 30 min; 95uC, ten min; followed by 40 cycles of 95uC,15 s; and 60uC, 1 min and analyzed applying ABI Prism 7900HT sequence detection method. Values had been normalized with GAPDH mRNA levels. A single peak was observed in the dissociation curve  for each genes confirming the specificity of PCR solutions. True time mRNA fold adjust was calculated by the formula, 22DDCt. Percentages have been taken in the column totals. Chi-squared test for measure of association was applied to derive p worth. doi:10.1371/journal.pone.0090682.t005 Genomic DNA and mRNA extraction Genomic DNA from complete blood samples was extracted working with QIAamp DNA blood mini kit as outlined by the manufacturer's guidelines. Genomic DNA and mRNA from vein tissues have been extracted by All Prep DNA/RNA/Protein mini kit. Quantification and purity of DNA and mRNA was measured by nanodrop-1000 spectrophotometer at 260 nm. RNA was additional treated with DNase1 for removing any DNA contamination. FoxC2 protein expression analysis by western blot Frozen vein tissues have been homogenized and incubated in ice-cold RIPA buffer with protease inhibitor cocktail for 90 minutes followed by centrifugation at 15,000 g for 20 min at 4uC to collect 4 FoxC2 in Chronic Venous Illness the supernatant. Proteins have been estimated by using Bradford reagent.&lt;/div&gt;</summary>
		<author><name>Smile05person</name></author>	</entry>

	</feed>